六种颅内动脉粥样硬化性大血管闭塞预测评分的外部验证
本研究利用双中心前瞻性卒中登记数据,对6种区分颅内动脉粥样硬化性大血管闭塞与栓塞性大血管闭塞的预测评分进行外部验证。共纳入91例接受机械取栓的患者,其中ICAD-LVO 18例。结果显示REMIT评分在总体人群中具有统计学意义的区分能力,影像标志物尤其是非责任血管狭窄对识别ICAD-LVO有临床价值。
要点
- REMIT评分在外部验证中对区分ICAD-LVO与栓塞性LVO具有统计学意义,可优先参考。
- 非责任血管狭窄是识别ICAD-LVO的重要影像线索,阅片时应主动评估。
- 各评分在ICAD-LVO事件数较少时估计不精确,临床应用需结合血管造影结果综合判断。
核心结论
- REMIT评分在总LVO人群中显示有统计学意义的区分能力,可用于识别ICAD-LVO。
- 非责任血管狭窄等影像标志物对区分ICAD-LVO与栓塞性LVO具有临床价值。
研究设计与样本
- 基于前瞻性维持的双中心卒中登记进行的外部验证研究,纳入2021年6月至2025年3月连续接受机械取栓且临床与影像资料完整的患者。
- 共筛查1288例入院患者,91例满足全部6种评分计算所需资料,其中ICAD-LVO 18例,栓塞性闭塞73例。
- LVO病因依据血管内治疗期间的血管造影表现确定。
- 每种评分的区分性能以受试者工作特征曲线下面积AUC进行评估。
关键影像表现/征象
- 影像显示非责任血管狭窄是识别ICAD-LVO的临床有用征象。
诊断标准与关键数值
- ISAT评分AUC为0.870,95%CI 0.664-1.000,P=0.064。
- REMIT评分AUC为0.793,95%CI 0.676-0.911,P<0.001。
- Score-ICAD评分AUC为0.707,95%CI 0.582-0.833,P=0.013。
- ABC2D评分AUC为0.627,95%CI 0.504-0.751,P=0.095。
- ATHE评分AUC为0.542,95%CI 0.396-0.687,P=0.617;ICAS-LVO评分AUC为0.465,95%CI 0.301-0.630,P=0.650。
临床应用与阅片要点
- 对拟行机械取栓的前循环大血管闭塞患者,可计算REMIT评分辅助术前判断ICAD-LVO可能性。
- 阅片时应重点关注非责任血管有无狭窄,将其作为提示ICAD-LVO的重要影像线索写入报告。
- 因ICAD-LVO事件数少导致多数评分估计不精确,不应单独依赖评分,需结合术中血管造影结果。
局限性
- ICAD-LVO事件数有限,多个评分的估计不精确。
- 部分评分因亚组限制而估计不精确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose- Intracranial atherosclerotic disease-related large vessel occlusion (ICAD-LVO) presents distinct challenges, particularly regarding the high risk of reocclusion and the need for specific management strategies. While several prediction scores exist to differentiate ICAD-LVO from embolic LVO (EMB-LVO), their external validity remains unproven. We aimed to externally validate six established prediction scores for differentiating the two. Methods- We analyzed data from a prospectively maintained, two-center stroke registry (June 2021-March 2025). Consecutive patients who underwent mechanical thrombectomy and had complete clinical and imaging data necessary for calculating six scores (ISAT, REMIT, ABC2D, ATHE, ICAS-LVO, and Score-ICAD) were included. LVO etiology was defined based on angiographic findings during endovascular treatment. The discriminative performance of each score was assessed using the area under the receiver operating characteristic curve (AUC). Results- Of 1,288 screened admissions, 91 patients met the inclusion criteria (ICAD-LVO, n = 18; embolic occlusion, n = 73). The AUCs (95% confidence interval) for differentiating etiology were: ISAT, 0.870 (0.664-1.000; P = 0.064); REMIT, 0.793 (0.676-0.911; P < 0.001); Score-ICAD, 0.707 (0.582-0.833; P = 0.013); ABC2D, 0.627 (0.504-0.751; P = 0.095); ATHE, 0.542 (0.396-0.687; P = 0.617); and ICAS-LVO, 0.465 (0.301-0.630; P = 0.650). Conclusion:In this external validation cohort, the REMIT scale showed statistically significant discrimination in the full LVO population, although estimates for several scales were imprecise because of the limited number of ICAD-LVO events and subgroup restrictions. Imaging markers, particularly non-culprit stenosis, appeared to provide clinically useful information for identifying ICAD-LVO.
引用
- Sakuta, Nakada, Sakai, et al. External validation of six prediction scores for differentiating intracranial atherosclerotic disease-related large vessel occlusion from embolic large vessel occlusion. Eur J Radiol. 2026. PMID: 42520379. doi:10.1016/j.ejrad.2026.113096
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。